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The phenomenon of "itchy skin", the appearance of itching on light tactile
stimulation in an area of skin surrounding an injury or injection of histamine,
was first described and characterized by Bickford (1). This altered state of the
skin was shown to depend on the spread of impulses from the original site of in-
jury through a local axonic pathway separate from those responsible for hyper-
algesia and flare. Evidence was presented that the fibers mediating itchy skin
are separate from those involved in the spontaneous itch occurring at the site of
injury or of the histamine injection. To our knowledge, no further investiga-
tions have been reported on this phenomenon.
The present report offers evidence that itchy skin produced by histamine is par-
tially or completely inhibited by the local action of tetraethylammonium; while
spontaneous itch, flare and hyperalgesia are not affected. The significance of
this finding will be considered in relation to Bickford's work.
METHOD
The subjects of the experiments were workers in the laboratory. All were
intelligent individuals, whose responses to the procedures were considered depend-
able. In addition, observations were made on three patients, with varicose
ulcers or pyoderma of the legs. In all, 21 subjects were tested, including both
sexes and representatives of white, Negro, and mongoloid races.
Itchy skin was produced by the injection of 0.1 cc. of histamine dihydrochloride,
1:2000, in normal saline into the skin of the volar surface of one forearm. Into
the corresponding area of the opposite arm 0.1 cc. of histamine 1: 2000 in solu-
tion with 5% tetraethylammonium chloride was injected. In a few cases, in-
jections were made in the upper arm. This area was less convenient to test than
the forearm, but results were similar in both locations.
The appearance of spontaneous itching at the site of injection, the size of the
wheal and extent of the surrounding flare were noted in each instance. Hyper-
algesia was tested by lightly rubbing the skin with the finger, and itchy skin was
elicited by gently stroking with a wisp of cotton gauze.
RESULTS
A total of 28 tests were made on 21 subjects. In every case the typical his-
tamine wheal and flare were observed, and no difference could be detected be-
tween the control and the tetraethylammonium sides. Hyperalgesia was elicited
on the control side in 9 tests, and in 7 of these was also present in the same inten-
sity with tetraethylammonium. Spontaneous itch was produced at the control
site in all but 5 instances; the same result was obtained in the test area.
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Itchy skin was produced by histamine in saline in 16 tests on 13 subjects. The
addition of tetraethylammonium caused either complete inhibition or marked
suppression of this state in 12 of these trials. In 1 case the sensations were iden-
tical in both arms, while in 3 cases the intensity of the itchy skin was greater on
the tetraethylammonium than on the control side. Upon retesting one of the
subjects who showed this reversal, the inhibitory action of tetraethylammonium
was manifested.
DISCUSSION
From these results, it is apparent that in the great majority of instances tet-
raethylammonium partially or completely inhibits the development of itchy skin
induced by intracutaneous histamine. This agent, however, has no effect on the
wheal, flare and hyperalgesia produced by histamine, nor on spontaneous itch.
This phenomenon cannot be explained on the basis of the known ganglionic
blocking action of tetraethylammonium (2). Recently, Janowitz and Grossman
(3) have shown that tetraethylammonium, injected locally, blocks the axon re-
flexes for sweating and pilomotion elicited by acetylcholine; Rothman and Coon
(4) showed that these axon reflexes could be set up, not only through injection
of acetylcholine, but also with nicotine and lobeline, These findings suggested
that the receptor sites of the afferent arms of the axon branches act in a manner
analogous to sympathetic ganglia. Thus the blocking action of tetraethylam-
monium in these instances can be considered to be on a basis analogous to its
action on the ganglia. There is, however, no reason to believe in a similar mec-
anism for the blocking of itchy skin. Apparently, then, this is the first report
of a blocking action of tetraethylammonium not related to a nicotinic effect.
If we consider, with Bickford, that the spread of the altered excitability is
through an autonomous system of branching axons, and that these release at
their endings some substance which lowers the threshold of the sensory endings
mediating itch, then it must be concluded that tetraethylammonium selectively
blocks the local action of histamine on this plexus. It is extremely unlikely that
tetraethylammonium spreads through the skin to block the sensory receptors
for itch, for in that case one would expect a slowly spreading inhibition from
the central point. On the contrary, tetraethylammonium inhibits itchy skin
over the whole area simultaneously.
It is difficult to explain why only one of the systems of peripheral nerves ac-
tivated by histamine should be blocked. It was suggested by Bickford's work
that the axon system responsible for itchy skin is distinct from those responsible
for hyperalgesia and flare; and Lewis (5) showed the latter two to be separate.
Despite this hypothesis of at least three different sets of nerves, there was no
suggestion that the mechanisms of their activation by histamine were different.
The present results, however, suggest that these mechanisms are different.
Moreover, the present findings support Bickford's contention that not only is
itchy skin mediated over a nerve system different from those of hyperalgesia and
flare, but that the mechanism is different from that of spontaneous itch. On
the basis of these results alone, it might still perhaps be true that hyperalgesia
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is brought about through a supraminimal activity of the same nerves which on
minimal stimulation produce itchy skin; in this case the failure of tetraethylam-
monium to block hyperalgesia would be due to insufficient concentration of the
drug. Having accepted Bickfcrd's argument, however, one need not make such
an assumption. As for the relation between itchy skin and spontaneous itch, our
results by themselves are inconclusive for it is conceivable that the failure
of action of tetraethylammonium on spontaneous itch is due to its inability to
block the direct effect of histamine on the itch receptors, in the concentration
used. Nevertheless, an analysis of the problem reveals that the fiber systems
responsible for spontaneous itch and for itchy skin must be separate. If impul-
ses are spreading centrifugally from the initial site of stimulation over a branch-
ing system of nerves, it is difficult to conceive of impulses travelling centrally
over the same fibers, simultaneously. Thus it would seem to be necessary to
accept the hypothesis of a distinct axon plexus for mediation of the altered state,
separate from the sensory system mediating the sensation of itch.
As yet, no definite statement can be made as to the application of the present
findings to clinical itching conditions, and their management. In a preliminary
study, one of us (6) has observed favorable response to intramuscularly admin-
istered tetraethylammonium chloride in some cases of itching disease.
SUMMARY
Tetraethylammonium chloride, in a 5% solution, in most cases inhibits to-
tally or partially the production of itchy skin by histamine dihydrochloride
1:2000. There is no apparent effect on the spontaneous itch, wheal, flare or
hyperalgesia produced by histamine.
Tetraethylammonium apparently acts by selectively inhibiting the action of
histamine on the branching axon system responsible for itchy skin. The re-
suits are in accord with Bickford's postulate that spontaneous itch and itchy skin
are distinct phenomena; this also holds for the separateness of itchy skin and
hyperalgesia.
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